Lancashire and South Cumbria
Formulary
4 Central nervous system
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
04-02-03 Carbamazepine
Carbamazepine
Formulary
See section 4.8.1 for epilepsy indications
Links
LMMG SCG Lithium July 2019
LMMG SCG Lithium July2019
LSCMMG: Shared care guideline
LSCMMG: Shared care guideline
LSCMMG: Shared care guideline
MHRA Drug SAfety Update April 2018: Valproate medicines (Epilim, Depakote): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met
MHRA Drug Safety Update April 2019: Valproate medicines and serious harms in pregnancy: new Annual Risk Acknowledgement Form and clinical guidance from professional bodies to support compliance with the Pregnancy Prevention Programme
MHRA Drug Safety Update April2018: Valproate medicines (Epilim, Depakote): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met
MHRA Drug Safety update Feb 2016 : Valproate and of risk of abnormal pregnancy outcomes: new communication materials
MHRA Drug Safety Update Feb 2016: Valproate and of risk of abnormal pregnancy outcomes: new communication materials
MHRA Drug Safety Update Sept 2018: Valproate Pregnancy Prevention Programme: actions required now from GPs, specialists, and dispensers
MHRA Drug Safety Update Sept 2018: Valproate Pregnancy Prevention Programme: actions required now from GPs, specialists, and dispensers
MHRA: Valproate use in men: as a precaution, men and their partners should use effective contraception
MHRA: Valproate use in men: as a precaution, men and their partners should use effective contraception
NICE CG103: Delirium: prevention, diagnosis and management
NICE CG178 Psychosis and schizophrenia in adults: prevention and management
NICE CG38: Bipolar disorder: Bipolar disorder: assessment and management
UHMB Lithium therapy risk assessment form
UHMB Lithium therapy risk assessment form
UHMB lithium therpay risk assessment form
Key
Full Site